Holen Sie sich die Stockscreener-App
69.17
1.43%
-1.00
Handel nachbörslich:
69.40
0.23
+0.33%
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
Boston Scientific at American College of Cardiology: Clinical Trials Drive Growth - Investing.com
Boston Scientific Unveils “Practice-Transforming” Trial Data for PE and AF at ACC Conference Call - Yahoo Finance
One-time heart implant cut bleeding vs. blood thinners in 3,000-patient trial - Stock Titan
HI-PEITHO trial demonstrates Boston Scientific EKOS™ Endovascular System is superior to standard of care for treatment of acute pulmonary embolism – Company AnnouncementFT.com - Financial Times
25,000 Shares in Boston Scientific Corporation $BSX Bought by Waycross Partners LLC - MarketBeat
Boston Scientific Corp (NYSE:BSX) Presents a Compelling Mix of Strong Fundamentals and Technical Breakout Potential - ChartMill
Avity Investment Management Inc. Has $20.76 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corp at TD Cowen Healthcare Conference Transcript - GuruFocus
Boston Scientific (NYSE:BSX) Cut to "Hold" at Wall Street Zen - MarketBeat
Boston Scientific Corp. stock underperforms Friday when compared to competitors - MarketWatch
BSX Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com
Bernstein reiterates Boston Scientific stock rating ahead of trial data - Investing.com
BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit - Barchart.com
Boston Scientific Corp Stock (BSX) Moved Up by 3.66% on Mar 26: Key Drivers Unveiled - TradingKey
Boston Scientific Corp. Stock: Navigating Electrophysiology Challenges Amid Strong Cardiovascular Gr - AD HOC NEWS
Portnoy Law Firm Announces Class Action on Behalf of Boston Scientific Corporation Investors - GlobeNewswire Inc.
BOSTON SCIENTIFIC CORPORATION (BSX) SHAREHOLDER ALERT - GlobeNewswire
Why The Narrative Around Boston Scientific (BSX) Is Shifting As Analysts Reset Expectations - Yahoo Finance
SG Americas Securities LLC Sells 19,225 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corp. stock faces pressure amid medtech sector slowdown and pipeline delays - AD HOC NEWS
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
BSX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
Boston Scientific (BSX): Company Profile, Stock Price, News, Rankings - Fortune
Boston Scientific: Under Pressure, But Could See A Shift In Fortunes (Rating Upgrade) - Seeking Alpha
Boston Scientific (BSX) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines – BSX - ChartMill
Is Boston Scientific Corporation (BSX) A Good Stock To Buy Now? - Insider Monkey
Boston Scientific Corp. stock shows resilient fundamentals amid volatile medtech market pressures - AD HOC NEWS
Why Boston Scientific's Big Dip Could Be a Bigger Opportunity - The Globe and Mail
BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - GlobeNewswire Inc.
Deadline Alert: Boston Scientific Corporation (BSX) - GlobeNewswire
A Quick Look at Today's Ratings for Boston Scientific(BSX.US), With a Forecast Between $90 to $120 - 富途牛牛
BSX Shareholder Alert: Boston Scientific Corporation Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm - Barchart
Evercore ISI reiterates Boston Scientific stock rating on growth outlook - Investing.com UK
Evercore ISI reiterates Boston Scientific stock rating on growth outlook By Investing.com - Investing.com India
Stifel reiterates Boston Scientific stock rating ahead of trial data - Investing.com
Boston Scientific (BSX) Joins Evercore's Tactical Outperform Lis - GuruFocus
Boston Scientific Corporation $BSX Shares Sold by Park Avenue Securities LLC - MarketBeat
BSX Stock Quote Price and Forecast - CNN
Avanza Fonder AB Acquires 21,210 Shares of Boston Scientific Corporation $BSX - MarketBeat
Robbins LLP Urges BSX Stockholders Who Lost Money Investing in Boston Scientific Corporation to Contact the Firm for Information About Leading the Class Action - Barchart.com
Westview Management dba Westview Investment Advisors Buys New Stake in Boston Scientific Corporation $BSX - MarketBeat
ROSEN, A RANKED AND LEADING FIRM, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
BSX INVESTOR ALERT: Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – RGRD Law - The Norfolk Daily News
Boston Scientific (NYSE:BSX) Falls as Recall Draws S&P 500 Focus - Kalkine Media
Tounjian Advisory Partners LLC Makes New Investment in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific’s EMEA Urology Push May Reframe Valuation Story - simplywall.st
Is Boston Scientific (BSX) Still Attractive After Its Recent Share Price Pullback? - Yahoo Finance
BSX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com
Truist Cuts PT on Boston Scientific Corporation (BSX) to $92 From $95 – Here’s Why - Insider Monkey
Boston Scientific Corp (BSX) Stock Price, Trades & News - GuruFocus
Jim Cramer on Boston Scientific: “This Stock Was One of the Greatest Performers, It’s Not Anymore” - Insider Monkey
BSX Shareholder Alert: May 4, 2026 Lead Plaintiff Deadline - GlobeNewswire
Needham & Company LLC Reiterates "Buy" Rating for Boston Scientific (NYSE:BSX) - MarketBeat
BOSTON SCIENTIFIC CORP ($BSX) CEO 2025 Pay Revealed - Quiver Quantitative
Boston Scientific Corp. stock underperforms Thursday when compared to competitors - MarketWatch
ROSEN, SKILLED TRIAL COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Boston Scientific (BSX) Faces Scrutiny Over Pacemaker Battery Re - GuruFocus
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces a Securities Fraud Class Action Lawsuit Has Been Filed Against Boston Scientific Corporation (BSX) - TMX Newsfile
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming DeadlinesBSX - ChartMill
BSX DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com
Is Boston Scientific Corp. (BSX) Pull Back Overdone as Financial Results Impress? - MSN
INVESTOR ALERT: Boston Scientific Corporation Investors - GlobeNewswire
Boston Scientific Faces Investor Lawsuit Alleging Misleading Statements About Electrophysiology Growth - TipRanks
0.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):